Exercise-induced growth hormone response in euglycaemia and hyperglycaemia in patients with Type 1 diabetes mellitus.

What Was Tested

This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

To compare exercise-induced growth hormone (GH) response in patients with Type 1 diabetes during stable euglycaemic and hyperglycaemic conditions.

Who Took Part

By PubMed's age tags, the people studied were adults, men only.

The researchers conducted a randomized, controlled, single-blinded cross-over trial in seven male patients with well-controlled Type 1 diabetes.

How the Study Was Run

The researchers set it up as a randomized, single-blind and crossover study.

Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.

Only one side, usually the participants, was kept unaware of whether Exogenous HGH, sermorelin & older GHRPs (why they're passed over) was given.

Each person switched between Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and the comparison at some point, usually with a gap in between.

What Was Measured

Topics PubMed links to this paper include Area Under Curve, Blood Glucose, Diabetes Mellitus, Type 1, Exercise, Exercise Test, Glucose Clamp Technique and Growth Hormone.

What This Means in Plain Language

The paper is a randomized, single-blind and crossover study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2010 (Diabetic medicine : a journal of the British Diabetic Association), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.